Weidinger, S;Baurecht, H;Wagenpfeil, S;Henderson, J;Novak, N;Sandilands, A;Chen, H;Rodriguez, E;O'Regan, GM;Watson, R;Liao, H;Zhao, Y;Barker, JN;Allen, M;Reynolds, N;Meggitt, S;Northstone, K;Smith, GD;Strobl, C;Stahl, C;Kneib, T;Klopp, N;Bieber, T;Behrendt, H;Palmer, CN;Wichmann, HE;Ring, J;Illig, T;McLean, WH;Irvine, AD
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk.
J Allergy Clin Immunol
2008
122
3
560-8.e4